Word

PDPS

Status

Pending

Status Code

641

Status Date

Wednesday, February 7, 2024

Serial Number

97933969

Mark Type

4000

Filing Date

Friday, May 12, 2023

Trademark Owner History

PeptiDream Inc.

Classifications

40 Manufacturing of synthetic peptides for others; Peptide synthesis for others; Manufacturing of pharmaceuticals and chemicals for others; Manufacturing of synthetic proteins for others; Amino acid synthesis for others

5 Synthetic peptides for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Pharmaceutical protein; Central nervous system drugs; Peripheral nerve drugs; Drugs affecting sensory organs; Antiallergic drugs; Cardiovascular drugs; Drugs affecting respiratory organs; Drugs affecting digestive organs; Drugs for outer skin; Blood solvent; Metabolic drugs; Cellular function activating drugs; Drugs for tumor treatment; Diagnostic drugs; Other drugs

1 Chemical products; Chemicals for the manufacture of pharmaceuticals; Peptide; Analytical samples for research; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and peptides used in the research, development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use

42 Testing, examination or research related to pharmaceuticals, cosmetics, or foods, and the provision of information or advice thereto; Testing, examination, or research related to organisms or bacteria, and the provision of information or advice thereto; Testing, examination, or research related to chemistry, and the provision of information or advice thereto; Testing, examination, or research related to medical care, and the provision of information or advice thereto; Testing, examination, or research related to biotechnology, and the provision of information or advice thereto; Testing, examination, or research related to the identification of hit lead peptides, and the provision of information or advice thereto; Testing, inspection, or research related to the identification of hit-lead compounds, and the provision of information or advice thereto; Testing, inspection, or research related to the analysis and synthesis of peptides, and the provision of information or advice thereto Testing, inspection, or research related to the analysis and synthesis of proteins, and the provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testing, examination, or research using automated screening machines and the provision of information or advice thereto; Clinical Trials; Quality control; Advice on quality control

Trademark Events

Feb 7, 2024

Notification Of Non-Final Action E-Mailed

Feb 7, 2024

Non-Final Action E-Mailed

Feb 7, 2024

Non-Final Action Written

Feb 6, 2024

Assigned To Examiner

Jun 12, 2023

New Application Office Supplied Data Entered

May 16, 2023

New Application Entered